Evolution of the global biosimilars market: Lessons learned
Driving the burgeoning biosimilars industry is the lucrative biologics market, worth billions
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Driving the burgeoning biosimilars industry is the lucrative biologics market, worth billions
What’s new in Canada? New biologic approvals by Health Canada for
Competition in the small molecule market is clearly divided into two categories
The major factors that will most affect the evolution of the biosimilar
Gastric ulcers are part of a chronic relapsing disease that is well
This work deals with the tunisian experience in the redaction of guidelines
The expiring patents related to drug/pharmaceuticals and advancements in Recombinant DNA
Expression systems encompass the technologies — biological materials and associated know-how — needed
Recent data tend to suggest that immune system in Rheumatoid Arthritis (RA
A biosimilar product is a biological product that is approved based on
Emerging Markets are taking on a greater level of prominence in the
This presentation will describe the market exclusivity provisions that apply to biosimilars
- Rational for the analytical toolbox - Sources of information to justify your analytical
SANDOZ filed an aBLA seeking the first approval of a U.S. biosimilar
Biosimilars are those biologics which are developed after patent expiration of innovator
The Biosimilar Era has arrived in the US! The past few months
The Biologics Price Competition and Innovation Act (BPCIA) was signed into law
Biologics sector in India has seen significant growth in last few years
When it comes to clearing the path for market entry of biosimilars
The Biologics Price Competition and Innovation Act of 2009 created an abbreviated
The regulatory landscape for the development of biosimilars in the US and
heavy metals, etc. have been developed successfully. In addition, various methods and sensors for bioanalysis & food analysis have been explored too. Furthermore, a series of electrochemical instruments has been…
demonstrate the additional need for a robust quality standard for analysis and bioanalysis of biotherapeutics. Industry-wide acceptance and application of a new quality standard would assure the consistency
Evaluation of the in-vivo concentration of monoclonal antibody (mAb) mixtures is
long run holds several exciting opportunities to any improvement. The most impact of bioanalysis within the pharmaceutical trade is to get a quantitative live of the drug and its metabolites ... review extensively…
For authors and organisers
Find the right journal for your paper and submit your manuscript.